Unaudited Financial Results for Quarter ended December 31, 2025.
Awaiting price reaction for this filing.
Omkar Speciality Chemicals has filed its unaudited results for the third quarter and nine months ending December 31, 2025. The company was under Corporate Insolvency Resolution Process (CIRP) during the period, and the NCLT approved its Resolution Plan on July 31, 2025. The auditor (R.R. Tibrewala & Co.) has issued a qualified opinion, flagging three issues: the company's insolvency status, the absence of comparative quarterly figures (as results were not prepared for the first three quarters of FY 2024-25), and reported losses. The Q1 review specifically flagged a negative net worth and material uncertainty around the going concern assumption, with losses continuing through the subsequent quarters.
This is a financially distressed company that recently emerged from insolvency proceedings — a significant risk signal for existing shareholders. While the approved Resolution Plan offers a path to revival, the auditor's qualification, negative net worth, and continued losses mean shareholders should temper expectations. Stock price likely remains highly speculative until operational and financial restructuring under the resolution plan shows tangible improvement.